Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine the effectiveness of postoperative Tamsulosin in
reducing the duration of acute postoperative urinary retention (POUR) following pelvic
reconstructive surgery through a double blind, randomized placebo-controlled trial.
Phase:
Phase 2
Details
Lead Sponsor:
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)